Cargando…
Intralymphatic immunotherapy
Gold Standard allergen-specific immunotherapy is associated with low efficacy because it requires either many subcutaneous injections of allergen or even more numerous sublingual allergen administrations to achieve amelioration of symptoms. Intralymphatic vaccination can maximize immunogenicity and...
Autores principales: | Senti, Gabriela, Kündig, Thomas M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4352255/ https://www.ncbi.nlm.nih.gov/pubmed/25780493 http://dx.doi.org/10.1186/s40413-014-0047-7 |
Ejemplares similares
-
Quality of life in allergic rhinitis patients treated with intralymphatic immunotherapy (ILIT): A 19-year follow-up
por: Adlany, Yasmin K., et al.
Publicado: (2022) -
Intralymphatic Immunotherapy (ILIT) With Bee Venom Allergens: A Clinical Proof-of-Concept Study and the Very First ILIT in Humans
por: Chabot, Alexandra, et al.
Publicado: (2022) -
Epicutaneous Immunotherapy for Aeroallergen and Food Allergy
por: Senti, Gabriela, et al.
Publicado: (2013) -
Allergen-specific intralymphatic immunotherapy in human and animal studies
por: Kim, Seon Tae, et al.
Publicado: (2017) -
Intralymphatic Histiocytosis
por: Garcia-Mouronte, Emilio, et al.
Publicado: (2022)